The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer

Creative Commons License

Gurbuz M., DOĞAN İ., AKKUŞ E., ÖZAKINCI H., Tolunay P. K., KALACI E., ...Daha Fazla

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, cilt.70, sa.2, ss.132-140, 2022 (ESCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 70 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5578/tt.20229803
  • Dergi Adı: TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, CAB Abstracts, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.132-140
  • Anahtar Kelimeler: Programmed cell death ligand 1, non-small cell lung cancer, clinicopathological parameters, immunotherapy, LIGAND 1 EXPRESSION, ASSOCIATION, FEATURES
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Introduction: Clinicopathological parameters related to programmed death ligand 1 (PD-L1) expression levels have been investigated in several studies. However, the results of these studies are conflicting and vary in different populations. This study aimed to investigate the relation of clinicopathological parameters with PD-L1 expression level in advanced stage non-small cell lung cancer patients.